PEAK6 Investments’s PRA Health Sciences, Inc. PRAH Stock Holding History

PEAK6 Investments’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,008	Closed	-$1.69M	–	6119
2021 Q1	$1.69M	Buy	11,008 +2,275	+26%	+$309K	﹤0.01%	2053
2020 Q4	$1.09M	Buy	8,733 +841	+11%	+$94K	﹤0.01%	2397
2020 Q3	$801K	Sell	7,892 -4,751	-38%	-$484K	﹤0.01%	2467
2020 Q2	$1.23M	Buy	12,643 +8,191	+184%	+$762K	﹤0.01%	1915
2020 Q1	$370K	Buy	+4,452	New	+$434K	﹤0.01%	2341
2019 Q4	–	Sell	-10,103	Closed	-$1M	–	4310
2019 Q3	$1M	Sell	10,103 -51,213	-84%	-$5.09M	0.01%	1763
2019 Q2	$6.08M	Buy	61,316 +40,223	+191%	+$3.84M	0.04%	587
2019 Q1	$2.33M	Buy	+21,093	New	+$2.2M	0.01%	1194
2018 Q4	–	Sell	-14,459	Closed	-$1.59M	–	4956
2018 Q3	$1.59M	Buy	+14,459	New	+$1.51M	0.01%	1617

Other funds holding PRAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

PEAK6 Investments's PRAH Position: Q2 2021 in Review

PEAK6 Investments sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 11,008 shares — an estimated $1.69M sold.

PEAK6 Investments first reported a position in PRAH in Q3 2018 and held it in 9 quarters. The position peaked at $6.08M in Q2 2019. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

PEAK6 Investments reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
PEAK6 Investments sold 11,008 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $1.69M.
PEAK6 Investments first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 9 quarters.
PEAK6 Investments's PRA Health Sciences, Inc. position peaked at $6.08M in Q2 2019.
317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on PEAK6 Investments's 13F filing for Q2 2021, filed 13 Aug 2021.